SecBot SecBot
144 ·Filed Nov 3, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed13d 7h ago SEC0001950047-26-010618
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is routine and small in scale relative to market cap. Monitor for any acceleration of insider selling patterns, but this single filing does not signal a change in fundamentals.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$15.95
T+0 close · Nov 3, 2026 · via day close
Latest settled
+2.38%
T+5 · $16.33 · next T+20 in 16d
Vs SPY
+3.30%
α at T+5
Latest observation
−1.13%
T+7 · FF3 residual α
  1. T+0 · Nov 4 $15.95entry
  2. T+1 · 12d ago −6.96%α −2.55% · $14.84
  3. T+5 · 6d ago +2.38%α +3.30% · $16.33
  4. T+8 · todayOpen
  5. T+20 · in 16d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Christine Ring, an officer of Nurix Therapeutics, filed a Form 144 notice of intent to sell 6,113 shares of common stock, with an estimated aggregate market value of approximately $157,104. The filing also discloses four prior 10b5-1 plan sales executed between September and November 2026, totaling 22,175 shares. This is a routine insider sale under a pre-arranged trading plan, representing a small fraction of the company's $3.0B market cap.

Key Facts

  • Christine Ring, an officer, filed Form 144 to sell 6,113 shares of common stock.
  • Estimated aggregate market value of the proposed sale is $157,104.10.
  • The filing also reports four prior 10b5-1 plan sales from September to November 2026 totaling 22,175 shares.
  • The proposed sale represents about 0.005% of the company's $3.0B market cap.
  • The filing is an advance notice of intent to sell; the sale may not occur.

Financial Impact

Proposed sale of 6,113 shares valued at ~$157K, or ~0.005% of market cap.

dilution

Risk Factors

  • Insider selling under a 10b5-1 plan is pre-arranged and not necessarily indicative of negative sentiment.
  • The filing is an intent to sell; the actual sale may not be executed.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010618
Document: 0001950047-26-010618-index.html0001950047-26-010618
Document: 0001950047-26-010618.txt0001950047-26-010618

Track record

33 reports on NRIX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +53.71% at T+20 after the Jun 8, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry price pending
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.17 Now $14.73 −2.90% settles Dec 15
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.41 Now $14.73 −4.41% settles Dec 15
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  7. Nov 3, 202613d ago 144 Neutral 2/10 Viewing Entry $15.95 Now $14.73 −7.65% settles Dec 3
  8. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $15.95 Now $14.73 +7.65% settles Dec 3
  9. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
Showing 10 of 33

US Market Status

Market Closed · Opens Wed (9h 52m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 3, 2026